|
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 3.09 NZD | +0.65% |
|
-1.59% | -11.71% |
AFT Pharmaceuticals Limited reported earnings results for the half year ended September 30, 2023. For the half year, the company reported sales was NZD 83.61 million compared to NZD 65.75 million a year ago. Net income was NZD 1.82 million compared to NZD 1.55 million a year ago.
Basic earnings per share from continuing operations was NZD 0.02 compared to NZD 0.01 a year ago.
| 1st Jan change | Capi. | |
|---|---|---|
| -11.71% | 192M | |
| +25.83% | 661B | |
| +27.00% | 566B | |
| -6.76% | 352B | |
| +20.34% | 332B | |
| +3.00% | 283B | |
| +13.09% | 231B | |
| +5.46% | 200B | |
| -9.61% | 195B | |
| -6.26% | 145B |
AFT PHARMACEUTICALS LIMITED 
